CUSIP 71722W107COMPHATQ4 2025
62 filings · latest Mar 12, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 12.47M | $206.82M |
| 2 | Medicxi Ventures Management (Jersey) Ltd | 7.46M | $123.84M |
| 3 | Invesco Ltd. | 3.92M | $65.04M |
| 4 | Blackrock, Inc. | 3.56M | $58.99M |
| 5 | Carlyle Group Inc. | 3.50M | $57.98M |
| 6 | Vanguard Group Inc | 3.18M | $52.71M |
| 7 | Ensign Peak Advisors, Inc | 2.35M | $39.02M |
| 8 | Millennium Management LLC | 2.08M | $34.54M |
| 9 |
| 4 | Nov 3, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 5.08M | SEC |
| 5 | Aug 28, 2025 | Carlyle Group Inc. | 13G/A | 11.0% | 3.50M | SEC |
| 6 | Aug 25, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 4.16M | SEC |
| 7 | Aug 20, 2025 | Frazier Life Sciences Public Fund, L.P. | 13D/A | 8.6% | — | SEC |
| 8 | Aug 13, 2025 | Millennium Management LLC | 13G | 11.0% | 3.76M | SEC |
| 9 | Jun 9, 2025 | Jennison Associates LLC | 13G/A | — | — | SEC |
| 10 | Jun 6, 2025 | Prudential Financial Inc | 13G/A | — | 2.6K | SEC |
See the full Schedule 13D/13G history for Phathom Pharmaceuticals Inc.
Unlock full history| Nea Management Company, LLC |
| 1.96M |
| $32.52M |
| 10 | 683 Capital Management, LLC | 1.78M | $29.61M |